跳至主要内容
临床试验/NL-OMON55045
NL-OMON55045尚未招募不适用

Fluoride PET-CT imaging for the detection of bone formation in (very) early and preclinical spondyloarthritis. - [18F]Fluoride PET in pre-SpA

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - First degree relative of HLA-B27 positive AxSpA patients
  • - Age between 18 and 40 years at time of inclusion
  • - Able and willing to give written informed consent
  • - 10 participants with an MRI highly suggestive of SpA according to the ASAS
  • definition at baseline
  • - 10 patients without an MRI highly suggestive of SpA according to the ASAS
  • definition at baseline

排除标准

  • - Patients already diagnosed with spondyloarthritis
  • - Individuals with concomitant conditions which may impact participation to the
  • study or interpretation of the data, such as:
  • - Individuals that have an arthritic disease, other than SpA
  • - Individuals that have a diagnosed condition with back pain other than
  • SpA (e.g. diagnosed intervertebral disc degenration)
  • - Individuals with communication problems
  • - Individuals with psychiatric diseases
  • - Individuals with drug abuse
  • - Individuals with a life expectancy less than 5 years
  • - Individuals who are pregnant or have a positive hcg urine test
  • - Individuals who are breastfeeding
  • - Individuals who have received treatment with any investigational drug
  • within previous 3 months
  • - Individuals who already received a research related radiation burden
  • (cumulative > 5 mSv) in the year before inclusion
  • - Other conditions by judgement of the physician

研究者

相似试验